Archive

Rebel Category: REBEL Cast

ANNEXA-1: Andexanet Alfa Associated with Harm in DOAC Reversal

Background: In May of 2018, Andexanet alfa gained accelerated approval by the FDA for the reversal direct oral anticoagulants (DOACs) despite a lack of robust evidence for use. The 2022 AHA/ASA guidelines give the drug a level 2A recommendation and ...

Read More
Hematology and OncologyNeurology

REBEL Core Cast 122.0 – Neutropenic Fever

Take Home Points: There are many causes of neutropenia, chemotherapy being by far the most dangerous. Febrile neutropenia is a condition conveying high mortality. Early administration of antibiotics is the only factor known to reduce this mortality. For a patient ...

Read More
Infectious Disease

REBEL Cast Ep126: Should We Not Be Recommending Small Adult BVMs in OHCA?

Background: The holy grail of outcomes in OHCA is survival with good neurologic outcome.  The only interventions proven to increase this outcome are high quality CPR and defibrillation in shockable rhythms.  Ventilation is also an important component of resuscitation in ...

Read More
Resuscitation

REBEL Core Cast 121.0 – Acute Sinusitis

Take Home Points Acute rhinosinusitis is a clinical diagnosis The vast majority of acute rhinosinusitis cases are viral in nature and do not require antibiotics Consider the use of antibiotics in select groups with severe disease or worsening symptoms after ...

Read More
Head, Eye, Ear, Nose, and ThroatInfectious Disease

REBEL Cast – EMTALA + Reproductive Health Rights

REBEL Cast – EMTALA + Reproductive Health Click here for Direct Download of the Podcast.

Read More
Ethical and LegalObstetrics and Gynecology

Sponsored